Latest Breaking News On - Allarity therapeutics receives nasdaq - Page 1 : comparemela.com

Allarity Therapeutics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250 Cambridge, MA U.S.A. - Allarity Therapeutics, Inc. , a clinical-stage. | April 22, 2022

United statesUnited kingdomThomas pedersenChuck padalaJens knudsenCompany contactCarrotize pr communicationsNasdaq hearings panelExchange commissionAllarity therapeutics incSmerud medical research internationalAllarity therapeutics receives nasdaqListing ruleListing qualifications departmentNasdaq stock marketNasdaq listing rule